BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19835635)

  • 1. Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia.
    Cho JY; Kim DM; Kwon YE; Yoon SH; Lee SI
    BMC Infect Dis; 2009 Oct; 9():171. PubMed ID: 19835635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report.
    She WH; Chok KSH; Li IWS; Ma KW; Sin SL; Dai WC; Fung JYY; Lo CM
    BMC Infect Dis; 2019 Jan; 19(1):66. PubMed ID: 30658592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
    Su YS; Lu JJ; Perng CL; Chang FY
    J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rare Case of 4 Ps: Bilateral Pneumothoraces and Pneumomediastinum in Pneumocystis Pneumonia.
    Yee D; Fu D; Hui C; Dharmadhikari N; Carino G
    R I Med J (2013); 2020 Jun; 103(5):52-54. PubMed ID: 32481782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complication of Pneumocystis jiroveci pneumonia.
    Mina NM; Soubani AO
    Respiration; 2011; 82(3):288-9. PubMed ID: 21701155
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumocystis jiroveci pneumonia and pneumomediastinum in an anti-TNFalpha naive patient with ulcerative colitis.
    Lee JC; Bell DC; Guinness RM; Ahmad T
    World J Gastroenterol; 2009 Apr; 15(15):1897-900. PubMed ID: 19370790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute psychosis related to use of trimethoprim/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: a multicentre, retrospective study.
    Lee KY; Huang CH; Tang HJ; Yang CJ; Ko WC; Chen YH; Lee YC; Hung CC
    J Antimicrob Chemother; 2012 Nov; 67(11):2749-54. PubMed ID: 22821870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
    Miller RF; Millar AB; Weller IV; Semple SJ
    Thorax; 1989 Jul; 44(7):559-64. PubMed ID: 2788935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China.
    Zhu M; Ye N; Xu J
    PLoS One; 2020; 15(9):e0238184. PubMed ID: 32911508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
    Kato H; Samukawa S; Takahashi H; Nakajima H
    J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumomediastinum in patients with AIDS: a case report and literature review.
    Cheng WL; Ko WC; Lee NY; Chang CM; Lee CC; Li MC; Li CW
    Int J Infect Dis; 2014 May; 22():31-4. PubMed ID: 24589680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia.
    Tyagi AK; Mirdha BR; Luthra K; Guleria R; Mohan A; Singh UB; Samantaray JC; Dar L; Iyer VK; Chaudhry R
    J Infect Dev Ctries; 2010 Nov; 4(11):761-6. PubMed ID: 21252456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis jiroveci pneumonia.
    Luks AM; Neff MJ
    Respir Care; 2007 Jan; 52(1):59-63. PubMed ID: 18330040
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole.
    Fisk M; Sage EK; Edwards SG; Cartledge JD; Miller RF
    Int J STD AIDS; 2009 Sep; 20(9):652-3. PubMed ID: 19710343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tension pneumomediastinum complicating Pneumocystis carinii pneumonia in acquired immunodeficiency syndrome.
    Rumbak MJ; Winer-Muram HT; Beals DH; Fry P
    Crit Care Med; 1992 Oct; 20(10):1492-4. PubMed ID: 1395675
    [No Abstract]   [Full Text] [Related]  

  • 16. Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients.
    Thomas M; Rupali P; Woodhouse A; Ellis-Pegler R
    Scand J Infect Dis; 2009; 41(11-12):862-8. PubMed ID: 19922070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic failure of trimethoprim/sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia.
    al-Tawfiq JA; Sorensen SJ; Cushing HE
    Ann Pharmacother; 1999 Apr; 33(4):413-5. PubMed ID: 10332530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
    Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
    Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pneumocystis Pneumonia in 107 HIV Infected Patients Admitted to the Department of Infectious Diseases at Santa Maria Hospital, Lisbon (2002 - 2013)].
    Grilo V; Pereira A
    Acta Med Port; 2016 Oct; 29(10):639-650. PubMed ID: 28103460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
    Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
    Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.